KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Sarepta Therapeutics (SRPT) over the last 14 years, with Q4 2024 value amounting to $6.3 million.

  • Sarepta Therapeutics' Non-cash Items fell 9782.45% to $6.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 million, marking a year-over-year decrease of 9782.45%. This contributed to the annual value of $6.3 million for FY2024, which is 9782.45% down from last year.
  • As of Q4 2024, Sarepta Therapeutics' Non-cash Items stood at $6.3 million, which was down 9782.45% from $288.1 million recorded in Q4 2023.
  • In the past 5 years, Sarepta Therapeutics' Non-cash Items ranged from a high of $288.1 million in Q4 2023 and a low of $2.0 million during Q4 2020
  • Moreover, its 5-year median value for Non-cash Items was $4.7 million (2022), whereas its average is $60.7 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 603988.73% in 2023, then crashed by 9782.45% in 2024.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Non-cash Items stood at $2.0 million in 2020, then rose by 25.35% to $2.5 million in 2021, then skyrocketed by 85.3% to $4.7 million in 2022, then surged by 6039.89% to $288.1 million in 2023, then plummeted by 97.82% to $6.3 million in 2024.
  • Its last three reported values are $6.3 million in Q4 2024, $288.1 million for Q4 2023, and $4.7 million during Q4 2022.